XML 13 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flow - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Mar. 31, 2023
Cash flows from operating activities          
Net loss including non controlling interest $ (30,610,414) $ 394,507 $ (65,798,667) $ (9,691,963)  
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization 451,773 521,544 1,232,626 1,293,803  
Stock based compensation     30,779,664 0  
Deferred income taxes     36,283 (42,729)  
Unrealised foreign exchange loss/(profit)     628,435 8,417  
Fair value losses in financial instruments carried at fair value     22,369,638 1,009,374  
Gain on fair valuation of investments     (1,812) 0  
Gain on sale of property and equipment     0 (495)  
Expected credit loss (net of reversal)     208,264 0  
Lease equalisation reserve     0 14,676  
Balances written off/(back)     0 209  
Changes in assets and liabilities, net of assets acquired and liabilities assumed from acquisitions:          
Inventories     30,013 (29,079)  
Income taxes, net     19,286 109,680  
Accounts receivables, net     2,412,838 (170,992)  
Prepayments and other assets     (24,935,177) (1,290,384)  
Accounts payable and accrued expenses and other current liabilities     19,656,629 1,730,544  
Other liabilities     (1,219,411) 87,564  
Net cash used in operating activities     (14,581,391) (6,971,375)  
Cash flows from investing activities          
Purchase of property and equipment, intangible assets and goodwill     (423,575) (326,972)  
Proceeds from sale of property, plant and equipment     0 1,096  
Acquisition of businesses     (5,749,202) 0  
Investment in mutual funds     (500,000) 0  
Net cash used in investing activities     (6,672,777) (325,876)  
Cash flows from financing activities          
Proceeds from business combination     32,770 0  
Proceeds from issue of preferred stock     6,079,409 0  
Proceeds from long-term borrowings     2,806,638 4,357,544  
Repayments of long-term borrowings     (1,025,884) (685,659)  
Net proceeds/(payments) from short-term borrowings     10,702,721 4,573,698  
Net cash generated from financing activities     18,595,654 8,245,583  
Effect of exchange rate changes on cash and cash equivalents     108,532 (109,747)  
Net (decrease)/increase in cash and cash equivalents (including restricted cash)     (2,549,982) 838,585  
Cash acquired in business combination     11,252,546 0  
Cash and cash equivalents at the beginning of the period (including restricted cash)     1,131,830 1,086,418 $ 1,086,418
Cash and cash equivalents at the end of the period (including restricted cash) 9,834,394 1,925,003 9,834,394 1,925,003 1,131,830
Reconciliation of cash and cash equivalents          
Cash and cash equivalents 9,406,697 1,283,615 9,406,697 1,283,615 589,340
Restricted cash 427,697 641,388 427,697 641,388 542,490
Total cash and cash equivalents $ 9,834,394 $ 1,925,003 9,834,394 1,925,003 $ 1,131,830
Supplemental disclosure of cash flow information          
Cash paid for interest, net of amounts capitalized     174,934 281,944  
Cash paid for income taxes, net of refunds     0 22,115  
Non-cash investing and financing activities          
Convertible preferred stock issued on conversion of convertible notes     0 6,441,014  
Consideration payable in connection with acquisitions     1,850,384 602,093  
Interest accrued on borrowings     $ 451,805 $ 0